Women Who Had Preeclampsia May Not Develop Breast Cancer

Women with a history of preeclampsia, a pregnancy complication characterized by high blood pressure, have as much as a 90% decrease in breast cancer risk if they carry a specific common gene variant.

Further studies are now underway to //determine the mechanism of this protection in an effort to develop new breast cancer prevention strategies for all women.

Pregnancy and Complications
In-depth guide for expecting mothers to overcome health complications related to early or late pregnancy. Anemia, urinary infection, diabetes, premature labor to name a few.

‘Women who develop high blood pressure in pregnancy have many associated changes in levels of hormones and growth factors, resulting in permanent protective breast tissue changes.’

Tweet it Now

The research, directed by lead author Mark Powell, MD, MPH, and Buck Institute professor Christopher Benz, MD, was carried out in the large California Teachers Study.

Women with preeclampsia were found to have a 74% lower risk of the most common type of breast cancer (hormone receptor positive) if they carried two T alleles of a variant of the insulin-like growth factor receptor gene when compared to women carrying no T alleles. This decrease in risk increased to 90% if the pregnancy with preeclampsia occurred before the age of 30.

"We are thrilled to work with researchers from our Scientific Advisory Board on this exciting project with the potential for developing a new approach to prevention. This very much fits with our goal of reducing the risk of breast cancer," said Rose Barlow, Executive Director of Zero Breast Cancer, which administered the study with funding from the Avon Foundation for Women.

Pregnancy Complications Increase Risk of Heart Disease in Offspring
High blood pressure; premature birth; and any respiratory, gut, genitourinary, malarial/dengue fever, measles, chickenpox increases risk of heart disease.

"This research could contribute to understanding the key impact of pregnancy on breast cancer risk, and may help explain why some women are protected while others are not," said Powell, who is a visiting scientist at the Buck Institute and is Director of the Breast Cancer Prevention Project.

Powell said women who develop high blood pressure in pregnancy have many associated changes in levels of hormones and growth factors, resulting in permanent protective breast tissue changes in women who carry the specific common gene variant.

Pregnancy Complications Linked to History of Acute Kidney Injury
Women with a history of acute kidney injury are more likely experience adverse pregnancy outcomes such as preeclampsia and premature birth.

Powell and Benz are now working on a major collaborative effort to identify the mechanism of this protective effect with the goal of developing badly needed new prevention strategies.

"Fellow researchers have demonstrated enormous interest in working with us," said Benz, who is also a practicing oncologist at the University of California San Francisco (UCSF). "This collective endeavor includes breast cancer investigators from UCSF, the Mayo Clinic, and many other leading research institutions."

HELLP Syndrome - Causes, Symptoms, Diagnosis, Treatment & Prognosis
HELLP syndrome is a rare but serious complication that affects pregnant women. If detected on time, it can be treated to prevent harm to the mother and the baby.

Working with the Komen Tissue Bank, Powell and Benz have obtained breast tissue from women identified as having high levels of protection, and are now analyzing this tissue in an effort to apply this naturally occurring process to all women.

"These study results may have a more immediate application in risk assessment," Powell added. "Research has shown this decrease in risk applies to women with gestational hypertension who carry the protective gene variant as well as those with preeclampsia. It is estimated that there are 9 million women in the U.S. whose risk could now be more accurately assessed, resulting in enhanced individualized breast cancer screening protocols."

Source-Eurekalert